Unblinding is always a good topic. Since it doesn’t mean we will get any information until the top line report comes out. Or maybe we will? One sure sign we will get is a sale of Leronlimab to the Philippines probably before we know anything or are provided both information at the same time. I feel that the unblinding is what they are waiting for before they pull the trigger on a purchase and are the first in line. The Philippines and the MHRA and the FDA are all waiting for the same mortality numbers if they haven’t got them already.

If we are not told the mortality numbers and all other regulatory agencies that requested early numbers receive it. Are we not suppose to receive any data within 4 days of knowledge of such transfer of data to others? SEC rules?

Dr. Randy Nicholas stated any day now for unblinding. I hope we get some early knowledge of mortality results before they spend a week or two analyzing the top line results for a completed paper to submit to the FDA.

Does anyone know if we are either entitled to the results for sure or if it is standard for Nader if he is allowed to, (FDA or OWS requirements) or will he just have a proactive video announcing results and maybe a possible first sale deal with the Philippines? That to me is hand in hand the same announcement when and if it happens.